Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects, age range 18 and over.~* Patient with acute neck pain meeting baseline pain intensity level and duration~Exclusion Criteria:~* Pain medication was taken within the 6 hours that precede randomization.~* Patient with chronic neck pain as defined as pain for 3 months or longer~* Any neck pain that is attributable to any organic disease, such as prolapsed disc, spondylolisthesis, osteomalacia, inflammatory arthritis, metabolic, neurological diseases or tumors.~* Any recent strains of the neck muscles documented by the clinical evaluation and anamnesis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diclofenac diethylamine 1.16% gel (Type: EXPERIMENTAL): None
- placebo gel (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).